Skip to main content
Erschienen in: Journal of Neurology 10/2013

01.10.2013 | Original Communication

The Movement Disorders Society criteria for the diagnosis of Parkinson’s disease dementia: their usefulness and limitations in elderly patients

verfasst von: Michèle Kiesmann, Jean-Baptiste Chanson, Julien Godet, Thomas Vogel, Laetitia Schweiger, Saïd Chayer, Georges Kaltenbach

Erschienen in: Journal of Neurology | Ausgabe 10/2013

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to assess the performance of the Movement Disorders Society (MDS) criteria for the diagnosis of Parkinson’s disease dementia (PDD) in the elderly, and also to evaluate the relevance of applying other tests in this patient population. The MDS criteria include a first short part in checklist form, and a second part which is used as a basis for reference and consists of an in-depth neuropsychological examination. Forty consecutive PD patients presenting with cognitive complaints were enrolled. An assessment was made of the performances of the MDS checklist compared with the MDS exhaustive cognitive examination which was used as a basis for reference, and with other cognitive tests including the Mattis Dementia Rating Scale (MDRS), the French version of the Grober and Buschke test, the verbal fluency test, the Rey–Osterreith complex figure and the paced auditory serial addition test. Out of a total of 40 PD subjects (mean age: 80.5 ± 4.9 years), 20 were diagnosed with PDD according to the checklist and 31 on the basis of the exhaustive examination, i.e. with 11 more patients diagnosed via the latter. The sensitivity of the checklist for the diagnosis of PDD was 0.64, with a specificity of 1.00. The use of the MDRS for PDD diagnosis with a cut-off at ≤120 showed a sensitivity of 0.80 and a specificity of 1.00, while at ≤132 it displayed a sensitivity of 1.00 and a specificity of 0.444. The specificity of the checklist for the diagnosis of PDD in the elderly was confirmed, but it was lacking in sensitivity. It was also found that the MDRS could be helpful in the diagnosis and screening of PDD.
Literatur
1.
Zurück zum Zitat de Rijk MC, Launer LJ, Berger K, Breteler MM, Dartigues JF, Balderesch M, Fratiglioni L, Lobo A, Martinez-Lage J, Trenkwalder C, Hofman A (2000) Prevalence of Parkinson’s disease in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the Elderly Research Group. Neurology 54:S21–S23PubMed de Rijk MC, Launer LJ, Berger K, Breteler MM, Dartigues JF, Balderesch M, Fratiglioni L, Lobo A, Martinez-Lage J, Trenkwalder C, Hofman A (2000) Prevalence of Parkinson’s disease in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the Elderly Research Group. Neurology 54:S21–S23PubMed
2.
Zurück zum Zitat Athey RJ, Porter RW, Walker RW (2005) Cognitive assessment of a representative community population with Parkinson’s disease (PD) using the Cambridge Cognitive Assessment-Revised (CAMCOG-R). Age Ageing 34(3):268–273PubMedCrossRef Athey RJ, Porter RW, Walker RW (2005) Cognitive assessment of a representative community population with Parkinson’s disease (PD) using the Cambridge Cognitive Assessment-Revised (CAMCOG-R). Age Ageing 34(3):268–273PubMedCrossRef
3.
Zurück zum Zitat de Lau LM, Schipper CM, Hofman A, Koudstaal PJ, Breteler MM (2005) Prognosis of Parkinson disease: risk of dementia and mortality: the Rotterdam study. Arch Neurol 62(8):1265–1269PubMedCrossRef de Lau LM, Schipper CM, Hofman A, Koudstaal PJ, Breteler MM (2005) Prognosis of Parkinson disease: risk of dementia and mortality: the Rotterdam study. Arch Neurol 62(8):1265–1269PubMedCrossRef
4.
Zurück zum Zitat Hobson P, Meara J (2004) Risk and incidence of dementia in a cohort of older subjects with Parkinson’s disease in the United Kingdom. Mov Disord 19:1043–1049PubMedCrossRef Hobson P, Meara J (2004) Risk and incidence of dementia in a cohort of older subjects with Parkinson’s disease in the United Kingdom. Mov Disord 19:1043–1049PubMedCrossRef
5.
Zurück zum Zitat Aarsland D, Zaccai J, Brayne C (2005) A systematic review of prevalence studies of dementia in Parkinson’s disease. Mov Disord 20(10):1255–1263PubMedCrossRef Aarsland D, Zaccai J, Brayne C (2005) A systematic review of prevalence studies of dementia in Parkinson’s disease. Mov Disord 20(10):1255–1263PubMedCrossRef
6.
Zurück zum Zitat Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sørensen P (2003) Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 60:387–392PubMedCrossRef Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sørensen P (2003) Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 60:387–392PubMedCrossRef
7.
Zurück zum Zitat Galvin JE, Pollack J, Morris JC (2006) Clinical phenotype of Parkinson disease dementia. Neurology 67:1605–1611PubMedCrossRef Galvin JE, Pollack J, Morris JC (2006) Clinical phenotype of Parkinson disease dementia. Neurology 67:1605–1611PubMedCrossRef
8.
Zurück zum Zitat Hely MA, Reid WGJ, Adena MA, Halliday GM, Morris JGL (2008) The Sydney Multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov Disord 23:837–844PubMedCrossRef Hely MA, Reid WGJ, Adena MA, Halliday GM, Morris JGL (2008) The Sydney Multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov Disord 23:837–844PubMedCrossRef
9.
Zurück zum Zitat Stern Y, Richards M, Sano M, Mayeux R (1993) Comparison of cognitive changes in patients with Alzheimer’s and Parkinson’s disease. Arch Neurol 50:1040–1045PubMedCrossRef Stern Y, Richards M, Sano M, Mayeux R (1993) Comparison of cognitive changes in patients with Alzheimer’s and Parkinson’s disease. Arch Neurol 50:1040–1045PubMedCrossRef
10.
Zurück zum Zitat Emre M, Aarsland D, Brown R et al (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22:1689–1707PubMedCrossRef Emre M, Aarsland D, Brown R et al (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22:1689–1707PubMedCrossRef
11.
Zurück zum Zitat Dubois B, Burn D, Goetz C et al (2007) Diagnostic procedures for Parkinson’s disease dementia: recommendations from the Movement Disorder Society Task Force. Mov Disord 22:2314–2324PubMedCrossRef Dubois B, Burn D, Goetz C et al (2007) Diagnostic procedures for Parkinson’s disease dementia: recommendations from the Movement Disorder Society Task Force. Mov Disord 22:2314–2324PubMedCrossRef
12.
Zurück zum Zitat Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinic-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCrossRef Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinic-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCrossRef
13.
Zurück zum Zitat Dujardin K, Duhamel A, Delliaux M, Thomas-Anterion C, Destée A, Defebvre L (2010) Cognitive complaints in Parkinson’s disease: its relationship with objective cognitive decline. J Neurol 257:79–84PubMedCrossRef Dujardin K, Duhamel A, Delliaux M, Thomas-Anterion C, Destée A, Defebvre L (2010) Cognitive complaints in Parkinson’s disease: its relationship with objective cognitive decline. J Neurol 257:79–84PubMedCrossRef
14.
Zurück zum Zitat Hughes CP, Berg L, Danzinger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140:566–572PubMedCrossRef Hughes CP, Berg L, Danzinger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140:566–572PubMedCrossRef
15.
Zurück zum Zitat Morris JC (1993) The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43:2412–2414PubMedCrossRef Morris JC (1993) The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43:2412–2414PubMedCrossRef
16.
Zurück zum Zitat Williams MM, Roe CM, Morris JC (2009) Stability of the Clinical Dementia Rating: 1979–2007. Arch Neurol 66(6):773–777PubMedCrossRef Williams MM, Roe CM, Morris JC (2009) Stability of the Clinical Dementia Rating: 1979–2007. Arch Neurol 66(6):773–777PubMedCrossRef
17.
Zurück zum Zitat Folstein MF, Folstein SE, McHugh PR (1975) ‘‘Mini-mental state’’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–199PubMedCrossRef Folstein MF, Folstein SE, McHugh PR (1975) ‘‘Mini-mental state’’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–199PubMedCrossRef
18.
Zurück zum Zitat McDonald WM, Holtzheimer PE, Haber M, Vitek JL, McWhorter K, Delong M (2006) Validity of the 30-item geriatric depression scale in patients with Parkinson’s disease. Mov Disord 21:1618–1622PubMedCrossRef McDonald WM, Holtzheimer PE, Haber M, Vitek JL, McWhorter K, Delong M (2006) Validity of the 30-item geriatric depression scale in patients with Parkinson’s disease. Mov Disord 21:1618–1622PubMedCrossRef
19.
Zurück zum Zitat Schrag A, Barone P, Brown RG et al (2007) Depression rating scales in Parkinson’s disease: critique and recommendations. Mov Disord 22(8):1077–1092PubMedCrossRef Schrag A, Barone P, Brown RG et al (2007) Depression rating scales in Parkinson’s disease: critique and recommendations. Mov Disord 22(8):1077–1092PubMedCrossRef
20.
Zurück zum Zitat Cardebat D, Doyon B, Puel M, Goulet P, Joanette Y (1990) Formal and semantic lexical evocation in normal subjects. Performance and dynamics of production as a function of sex, age and educational level. Acta Neurol Belg 90(4):207–217PubMed Cardebat D, Doyon B, Puel M, Goulet P, Joanette Y (1990) Formal and semantic lexical evocation in normal subjects. Performance and dynamics of production as a function of sex, age and educational level. Acta Neurol Belg 90(4):207–217PubMed
21.
Zurück zum Zitat Godefroy O, ‘Groupe de Reflexion sur l’Evaluation des Fonctions Executives’ (2008) Fonctions executives et pathologies neurologiques et psychiatriques. Solal, Marseille Godefroy O, ‘Groupe de Reflexion sur l’Evaluation des Fonctions Executives’ (2008) Fonctions executives et pathologies neurologiques et psychiatriques. Solal, Marseille
22.
Zurück zum Zitat Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression, and mortality. Neurology 17:427–442PubMedCrossRef Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression, and mortality. Neurology 17:427–442PubMedCrossRef
23.
Zurück zum Zitat Rosenthal E, Brennan L, Xie S, Hurtig H, Milber J, Weintraub D, Karlawish J, Siderowf A (2010) Association between cognition and function in patients with Parkinson disease with and without dementia. Mov Disord 25(9):1170–1176PubMedCrossRef Rosenthal E, Brennan L, Xie S, Hurtig H, Milber J, Weintraub D, Karlawish J, Siderowf A (2010) Association between cognition and function in patients with Parkinson disease with and without dementia. Mov Disord 25(9):1170–1176PubMedCrossRef
24.
Zurück zum Zitat Fahn S, Elton RL, The UPDRS Development Committee (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Calne D, Goldstein M (eds) Recent developments in Parkinson’s disease. Macmillan Health Care Information, Florham Park, pp 153–163 Fahn S, Elton RL, The UPDRS Development Committee (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Calne D, Goldstein M (eds) Recent developments in Parkinson’s disease. Macmillan Health Care Information, Florham Park, pp 153–163
25.
Zurück zum Zitat Mattis S (1976) Mental status examination for organic mental syndrome in the elderly patient. In: Bellak L, Karasy T (eds) Geriatric psychiatry. Grune and Stratton, New York, pp 77–121 Mattis S (1976) Mental status examination for organic mental syndrome in the elderly patient. In: Bellak L, Karasy T (eds) Geriatric psychiatry. Grune and Stratton, New York, pp 77–121
26.
Zurück zum Zitat Mattis S (1988) Dementia rating scale: professional manual. Psychological Assessment Resources, Odessa Mattis S (1988) Dementia rating scale: professional manual. Psychological Assessment Resources, Odessa
27.
Zurück zum Zitat Brown GG, Rahill AA, Gorell JM, McDonald C, Brown SJ, Sillanpaa M et al (1999) Validity of the dementia rating scale in assessing cognitive function in Parkinson’s disease. J Geriatr Psychiatry Neurol 12(4):180–188PubMedCrossRef Brown GG, Rahill AA, Gorell JM, McDonald C, Brown SJ, Sillanpaa M et al (1999) Validity of the dementia rating scale in assessing cognitive function in Parkinson’s disease. J Geriatr Psychiatry Neurol 12(4):180–188PubMedCrossRef
28.
Zurück zum Zitat Llebaria G, Pagonobarraga J, Kulisevsky J, Garcia-Sanchez C, Pascual-Sedano B, Gironell A, Martinez-Corral M (2008) Cut-off score of the Mattis dementia rating scale for screening dementia in Parkinson’s disease. Mov Disord 23:1546–1550PubMedCrossRef Llebaria G, Pagonobarraga J, Kulisevsky J, Garcia-Sanchez C, Pascual-Sedano B, Gironell A, Martinez-Corral M (2008) Cut-off score of the Mattis dementia rating scale for screening dementia in Parkinson’s disease. Mov Disord 23:1546–1550PubMedCrossRef
29.
Zurück zum Zitat Machulda MM, Ivnik RJ, Smith GE, Ferman TJ, Boeve BF, Knopman D et al (2007) Mayo’s older Americans normative studies: visual form discrimination and copy trial of the Rey–Osterrieth complex figure. J Clin Exp Neuropsychol 29:377–384PubMedCrossRef Machulda MM, Ivnik RJ, Smith GE, Ferman TJ, Boeve BF, Knopman D et al (2007) Mayo’s older Americans normative studies: visual form discrimination and copy trial of the Rey–Osterrieth complex figure. J Clin Exp Neuropsychol 29:377–384PubMedCrossRef
30.
Zurück zum Zitat Van der Linden M, Coyette F, Poitrenaud J, et al (2004) L’épreuve de rappel libre/rappel indice′ à 16 items (RL/RI-16). In: Van der Linden M, Grenem (eds) L’évaluation des troubles de la mémoire. Marseille, Solal, pp 25–47. Van der Linden M, Coyette F, Poitrenaud J, et al (2004) L’épreuve de rappel libre/rappel indice′ à 16 items (RL/RI-16). In: Van der Linden M, Grenem (eds) L’évaluation des troubles de la mémoire. Marseille, Solal, pp 25–47.
31.
Zurück zum Zitat Gronwall C (1977) Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills 44:367–373PubMedCrossRef Gronwall C (1977) Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills 44:367–373PubMedCrossRef
32.
Zurück zum Zitat Naeagele B, Mazza S. Paced auditory serial-addition task: version française dite modifiée. Editions Solal. Naeagele B, Mazza S. Paced auditory serial-addition task: version française dite modifiée. Editions Solal.
33.
Zurück zum Zitat Wancata J, Alexandrowicz R, Marquart B, Weiss M, Friedrich F (2006) The criterion validity of the geriatric depression scale: a systematic review. Acta Psychiatr Scand 114:398–410PubMedCrossRef Wancata J, Alexandrowicz R, Marquart B, Weiss M, Friedrich F (2006) The criterion validity of the geriatric depression scale: a systematic review. Acta Psychiatr Scand 114:398–410PubMedCrossRef
34.
35.
Zurück zum Zitat Riedel O, Klotsche J, Spottke A, Deuschl G, Förstl H, Henn F, Heuser I, Oertel W, Reichmann H, Riederer P, Trenkwalder C, Dodel R, Wittchen H-U (2008) Cognitive impairment in 873 patients with idiopathic Parkinson’s disease. Results from the German Study on Epidemiology of Parkinson’s Disease with Dementia (GEPAD). J Neurol 255:255–264PubMedCrossRef Riedel O, Klotsche J, Spottke A, Deuschl G, Förstl H, Henn F, Heuser I, Oertel W, Reichmann H, Riederer P, Trenkwalder C, Dodel R, Wittchen H-U (2008) Cognitive impairment in 873 patients with idiopathic Parkinson’s disease. Results from the German Study on Epidemiology of Parkinson’s Disease with Dementia (GEPAD). J Neurol 255:255–264PubMedCrossRef
36.
Zurück zum Zitat Balzer-Geldsetzer M, Ferreira Braga da Costa A-S, Kronenbürger M et al (2011) Parkinson’s disease and dementia. A longitudinal study (DEMPARK). Neuroepidemiology 37:168–176PubMedCrossRef Balzer-Geldsetzer M, Ferreira Braga da Costa A-S, Kronenbürger M et al (2011) Parkinson’s disease and dementia. A longitudinal study (DEMPARK). Neuroepidemiology 37:168–176PubMedCrossRef
37.
Zurück zum Zitat Barton B, Grabli D, Bernard B, Czernecki V, Goldman JG, Stebbins G, Dubois B, Goetz CG (2012) Clinical validation of Movement Disorder Society : recommended diagnostic criteria for Parkinson’s disease with dementia. Mov Disord 27:248–253PubMedCrossRef Barton B, Grabli D, Bernard B, Czernecki V, Goldman JG, Stebbins G, Dubois B, Goetz CG (2012) Clinical validation of Movement Disorder Society : recommended diagnostic criteria for Parkinson’s disease with dementia. Mov Disord 27:248–253PubMedCrossRef
38.
Zurück zum Zitat Di Battista ME, Giustini P, Bernardi S, Stirpe P, Vanacore N, Meco G (2011) A simplified algorithm may lead to overestimate dementia in PD. A clinical and epidemiological study using criteria for PD-D proposed by the Movement Disorders Task Force. J Neural Transm 118:1609–1612PubMedCrossRef Di Battista ME, Giustini P, Bernardi S, Stirpe P, Vanacore N, Meco G (2011) A simplified algorithm may lead to overestimate dementia in PD. A clinical and epidemiological study using criteria for PD-D proposed by the Movement Disorders Task Force. J Neural Transm 118:1609–1612PubMedCrossRef
39.
Zurück zum Zitat Dujardin K, Sockeel P, Delliaux M, Destee A, Defebvre L (2009) Apathy may herald cognitive decline and dementia in Parkinson’s disease. Mov Disord 24:2391–2397PubMed Dujardin K, Sockeel P, Delliaux M, Destee A, Defebvre L (2009) Apathy may herald cognitive decline and dementia in Parkinson’s disease. Mov Disord 24:2391–2397PubMed
40.
Zurück zum Zitat Dujardin K, Dubois B, Tison F, Durif F, Bourdeix I, Péré JJ, Duhamel A, Executive study group (2010) Parkinson’s disease dementia can be easily detected in routine clinical practice. Mov Disord 25:2769–2776PubMedCrossRef Dujardin K, Dubois B, Tison F, Durif F, Bourdeix I, Péré JJ, Duhamel A, Executive study group (2010) Parkinson’s disease dementia can be easily detected in routine clinical practice. Mov Disord 25:2769–2776PubMedCrossRef
41.
Zurück zum Zitat Hoops S, Nazem S, Siderowf AD, Duda JE, Xie SX, Stern MB, Weintraub D (2009) Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 73:1738–1745PubMedCrossRef Hoops S, Nazem S, Siderowf AD, Duda JE, Xie SX, Stern MB, Weintraub D (2009) Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 73:1738–1745PubMedCrossRef
42.
Zurück zum Zitat Nasreddine ZS, Phillips NA, Bedirian V et al (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699PubMedCrossRef Nasreddine ZS, Phillips NA, Bedirian V et al (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699PubMedCrossRef
43.
Zurück zum Zitat Biundo R, Weis L, Pilleri M, Facchini S, Formento-Dojot P, Vallelunga A, Antonini A (2013) Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson’s disease. J Neural Transm 120:627–633PubMedCrossRef Biundo R, Weis L, Pilleri M, Facchini S, Formento-Dojot P, Vallelunga A, Antonini A (2013) Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson’s disease. J Neural Transm 120:627–633PubMedCrossRef
44.
Zurück zum Zitat Grober E, Sanders AE, Hall C, Lipton RB (2010) Free and cued selective reminding identifies very mild dementia in primary care. Alzheimer Dis Assoc Disord 24:284–290PubMed Grober E, Sanders AE, Hall C, Lipton RB (2010) Free and cued selective reminding identifies very mild dementia in primary care. Alzheimer Dis Assoc Disord 24:284–290PubMed
45.
Zurück zum Zitat Aarsland D, Kurz MW (2010) The epidemiology of dementia associated with Parkinson’s disease. Brain Pathol 20(3):633–639PubMedCrossRef Aarsland D, Kurz MW (2010) The epidemiology of dementia associated with Parkinson’s disease. Brain Pathol 20(3):633–639PubMedCrossRef
46.
Zurück zum Zitat Martinez-Martin P, Falup-Pecurariu C, Rodriguez-Blazquez C, Serrano-Dueñas M, Carod Artal FJ, Rojo Abuin JM, Aarsland D (2011) Dementia associated with Parkinson’s disease: applying the Movement Disorder Society Task Force criteria. Parkinsonism Relat Disord 17:621–624PubMedCrossRef Martinez-Martin P, Falup-Pecurariu C, Rodriguez-Blazquez C, Serrano-Dueñas M, Carod Artal FJ, Rojo Abuin JM, Aarsland D (2011) Dementia associated with Parkinson’s disease: applying the Movement Disorder Society Task Force criteria. Parkinsonism Relat Disord 17:621–624PubMedCrossRef
47.
Zurück zum Zitat Matteau E, Dupré N, Langlois M, Provencher P, Simard M (2012) Clinical validity of the Mattis dementia rating scale-2 in Parkinson disease with MCI and dementia. J Geriatr Psychiatry Neurol 25:100–106PubMedCrossRef Matteau E, Dupré N, Langlois M, Provencher P, Simard M (2012) Clinical validity of the Mattis dementia rating scale-2 in Parkinson disease with MCI and dementia. J Geriatr Psychiatry Neurol 25:100–106PubMedCrossRef
Metadaten
Titel
The Movement Disorders Society criteria for the diagnosis of Parkinson’s disease dementia: their usefulness and limitations in elderly patients
verfasst von
Michèle Kiesmann
Jean-Baptiste Chanson
Julien Godet
Thomas Vogel
Laetitia Schweiger
Saïd Chayer
Georges Kaltenbach
Publikationsdatum
01.10.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 10/2013
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-013-7018-8

Weitere Artikel der Ausgabe 10/2013

Journal of Neurology 10/2013 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.